Director
Merck & Co., Inc.
Alice received her PhD from Purdue University in 2016 where her research focused on the oxidation of bioanalytes within a mass spectrometer via ion/ion reactions. After graduation she joined Merck & Co., Inc. in the Small Molecule Analytical R&D department where she supported programs in various stages of clinical development. One focus during this time was the definition of control strategy for large molecule impurities in small molecule APIs generated from biocatalytic routes. In 2019 Alice moved to the Analytical Method Development group in Biologics Analytical R&D focused on LC method development for biologics programs.